Summary
Johnson & Johnson (J&J) filed a Form 8-K on March 1, 2004, to report the issuance of its Annual Report. This filing includes crucial audited consolidated financial statements for the fiscal years ending December 28, 2003, December 29, 2002, and the preceding two years. Investors gain access to the company's complete financial performance and position as of these dates through the incorporated Management's Discussion and Analysis of Financial Condition and Results of Operations. The filing also incorporates the independent accountant's report, providing an independent auditor's opinion on the fairness and accuracy of J&J's financial statements. This material is essential for investors seeking to understand the company's financial health, operational performance, and the reliability of its reported figures for the period leading up to and including fiscal year 2003.
Key Highlights
- 1Filing of J&J's audited consolidated financial statements for the fiscal years ended December 28, 2003, December 29, 2002, and the two prior years.
- 2Inclusion of Management's Discussion and Analysis (MD&A) of Financial Condition and Results of Operations, providing management's perspective on financial performance.
- 3Incorporation by reference of the independent accountant's report, offering an auditor's opinion on the financial statements.
- 4The financial statements cover a three-year period, allowing for analysis of historical trends.
- 5The filing was made on March 1, 2004, with the event date being February 29, 2004, aligning with typical annual reporting cycles.
- 6Stephen J. Cosgrove, Chief Accounting Officer, signed the report, indicating executive oversight of financial reporting.